免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

DurAVR™ THV EU-EFS

NCT:NCT06510855 · ACTIVE_NOT_RECRUITING

NCT编号NCT06510855
状态ACTIVE_NOT_RECRUITING
开始日期2025-01-21
SponsorAnteris Technologies Ltd. (INDUSTRY)
First posted
Last updated

简要摘要

A prospective, non-randomized, single-arm, multi-center study designed to evaluate the safety and feasibility of DurAVR™ THV System in the treatment of subjects with symptomatic severe native aortic stenosis or failed surgical aortic bioprosthetic valves.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑